NeuroVia, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.neurovia-inc.com
A Study to Prospectively Assess Disease Progression in Male Children With X-ALD
- Conditions
- X-Linked Adrenoleukodystrophy
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- NeuroVia, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03278899
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy
Phase 1
Withdrawn
- Conditions
- X-Linked Adrenoleukodystrophy
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2019-03-07
- Lead Sponsor
- NeuroVia, Inc.
- Registration Number
- NCT03196765
- Locations
- 🇬🇧
Great Ormond Street Hospital for Children, London, United Kingdom
🇨🇱Hospital Clínico San Borja Arriarán, Santiago, Chile
🇷🇺Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation
© Copyright 2025. All Rights Reserved by MedPath